Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis

José A. Oteo1, Héctor Corominas2, Raquel Escudero3, Fernando Fariñas-Guerrero4, Juan Carlos García-Moncó5, Miguel A. Goenaga6, Sara Guillén7, José M. Mascaró8, Aránzazu Portillo1
1Centre of Rickettsiosis and Arthropod-Borne Diseases (CRETAV), Department of Infectious Diseases, San Pedro University Hospital - Centre for Biomedical Research from La Rioja (CIBIR), Logroño, Spain
2Spanish Society of Rheumatology, Rheumatology and Systemic Autoimmune Diseases Department, Hospital de la Santa Creu i Sant Pau/Hospital Dos de Maig, Barcelona, Spain
3Special Pathogens Reference and Research Laboratory, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain
4Spanish Society of Immunology. Institute of Clinical Immunology and Infectious Diseases, YNMUN Biomedicine Group, Málaga, Spain
5Spanish Society of Neurology. Department of Neurology, Hospital Universitario Basurto, Bilbao, Spain
6Infectious Diseases Service, Hospital Donostia, OSI Donostialdea. Instituto BioDonostia, San Sebastián, Spain
7Spanish Society of Pediatric Infectology (SEIP), Department of Pediatrics, Hospital Universitario de Getafe, Madrid, Spain
8Spanish Academy of Dermatology and Venereology, Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain

Tài liệu tham khảo

Dessau, 2018, To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis, Clin Microbiol Infect, 24, 118, 10.1016/j.cmi.2017.08.025 Figoni, 2019, Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis, Med Mal Infect, 49, 318, 10.1016/j.medmal.2019.04.381 Jaulhac, 2019, Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis, Med Mal Infect, 49, 335, 10.1016/j.medmal.2019.05.001 Mead, 2019, Updated CDC recommendation for serologic diagnosis of Lyme disease, MMWR Morb Mortal Wkly Rep, 68, 703, 10.15585/mmwr.mm6832a4 Rauer, 2020, Guidelines for diagnosis and treatment in neurology – Lyme neuroborreliosis, Ger Med Sci, 18 Talagrand-Reboul, 2020, Immunoserological diagnosis of human borrelioses: current knowledge and perspectives, Front Cell Infect Microbiol, 10, 241, 10.3389/fcimb.2020.00241 Lantos, 2021, Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease, Arthritis Care Res (Hoboken), 73, 1, 10.1002/acr.24495 Stupica, 2018, Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial, J Antimicrob Chemother, 73, 1352, 10.1093/jac/dkx534 Kortela, 2021, Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme neuroborreliosis: a multicenter, equivalence, randomized, open-label trial, Clin Infect Dis, 72, 1323, 10.1093/cid/ciaa217 Harms, 2021, A single dose of doxycycline after an Ixodes ricinus tick bite to prevent Lyme borreliosis: an open-label randomized controlled trial, J Infect, 82, 98, 10.1016/j.jinf.2020.06.032